BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Ljubljana
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190204
DTEND;VALUE=DATE:20190206
DTSTAMP:20260403T202653
CREATED:20190201T192309Z
LAST-MODIFIED:20190201T192309Z
UID:2253-1549238400-1549411199@carb-x.org
SUMMARY:Hamied Foundation UK-India Antimicrobial Resistance Meeting 2019
DESCRIPTION:The meeting is being organised as part of a programme of work to strengthen the research links between the UK and India with the specific aim of jointly addressing the challenge of AMR. \n 
URL:https://carb-x.org/event/hamied-foundation-uk-india-antimicrobial-resistance-meeting-2019/
LOCATION:The Hallam Conference Centre\, 44 Hallam Street\, London\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20190221T170000
DTEND;TZID=Europe/Paris:20190221T183000
DTSTAMP:20260403T202653
CREATED:20190206T170743Z
LAST-MODIFIED:20190214T192431Z
UID:2345-1550768400-1550773800@carb-x.org
SUMMARY:Webinar - NIAID Resources to Facilitate Discovery & Development of Anti-Infectives
DESCRIPTION:Speakers include Ann Eakin\, Senior Scientific Officer Office of Biodefense\, Research Resources & Translational Research\, DMID/NIAID/NIH\, member of the CARB-X Joint Oversight Committee. \nIn this presentation\, Ann Eakin (US National Institute of Allergy and Infectious Diseases\, NIAID) will provide an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs\, vaccines and diagnostics targeting infectious diseases. The types of support that will be discussed are grants and contracts\, as well as preclinical and clinical research services that aim to reduce risk and advance product development efforts. Researchers from any country and from any type of institution (academia\, industry\, non-profit) are eligible to apply for nearly all types of support mechanisms offered by NIAID\, irrespective of prior or current NIH funding. \nAnn’s presentation will be complemented by a short presentation of Dan Pevear\, Founder and Senior Vice President\, Biology and Grants Development\, VenatoRx Pharmaceuticals\, in which he will share VenatoRx’ experience with NIAID support mechanisms. \nThe presentations will be followed by a Q&A session. \n 
URL:https://carb-x.org/event/webinar-niaid-resources-to-facilitate-discovery-development-of-anti-infectives/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190306
DTEND;VALUE=DATE:20190307
DTSTAMP:20260403T202653
CREATED:20190206T154939Z
LAST-MODIFIED:20190206T154939Z
UID:2336-1551830400-1551916799@carb-x.org
SUMMARY:US FDA Regulatory Approval Process for Anti-microbials Workshhop
DESCRIPTION:Workshop hosted by the Centre for Cellular And Molecular Platforms (C-CAMP)\, a member of the CARB-X Accelerator Network.
URL:https://carb-x.org/event/us-fda-regulatory-approval-process-for-anti-microbials-workshhop/
LOCATION:C-CAMP\, Chausa\, Bengaluru\, India
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190314
DTEND;VALUE=DATE:20190316
DTSTAMP:20260403T202653
CREATED:20190201T192824Z
LAST-MODIFIED:20190214T181713Z
UID:2256-1552521600-1552694399@carb-x.org
SUMMARY:The 12th Berlin Conference on Life Sciences - Novel Antimicrobials and AMR Diagnostics 2019
DESCRIPTION:Speakers include Kevin Outterson\, CARB-X Executive Director. \nThe Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. \n 
URL:https://carb-x.org/event/thje-12th-berlin-conference-on-life-sciences-novel-antimicrobials-and-amr-diagnostics-2019/
LOCATION:Radisson Blu Hotel\, Karl-Liebknecht-Strasse 3\, Berlin\, 10178\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190321
DTEND;VALUE=DATE:20190323
DTSTAMP:20260403T202653
CREATED:20190201T193139Z
LAST-MODIFIED:20190220T163600Z
UID:2260-1553126400-1553299199@carb-x.org
SUMMARY:BSAC Spring Conference 2019
DESCRIPTION:Global views\, local problems: Innovative solutions to AMR and infection challenges. \nThe British Society for Antimicrobial Chemotherapy (BSAC) 2019 Spring Conference offers a state of the art overview of the infection management and antimicrobial resistance landscape. The programme includes keynote lectures\, plenary and parallel sessions\, debates and an opening series of spotlight presentations – offering insights into the latest in drug discovery and development\, socio-economic challenges\, new and emerging treatments and diagnostics and debates and challenges policies and usage of antibiotic regimens.  Globally focused and locally relevant\, the conference brings together key opinion leaders\, researchers and clinicians from across Europe and further afield. Alongside the networking and exhibition areas\, this event offers outstanding opportunities for education and engagement to all delegates.
URL:https://carb-x.org/event/bsac-spring-conference-2019/
LOCATION:International Convention Center\, 8 Centenary Square\, Birmingham\, B1 2EA\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190321T083000
DTEND;TZID=America/New_York:20190321T140000
DTSTAMP:20260403T202653
CREATED:20190206T153806Z
LAST-MODIFIED:20190214T181749Z
UID:2332-1553157000-1553176800@carb-x.org
SUMMARY:Longitude Prize AMR Diagnostics Boston Workshop
DESCRIPTION:Speakers include Kevin Outterson\, CARB-X Executive Director. \nThe Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an affordable\, accurate and rapid point-of-care diagnostic test. This test must be practical to use in the North America and Europe as well as low and middle-income countries (LMICs).  There are currently 83 teams competing for the Prize from 14 countries with a broad mix of entries from industry and academia. The Prize Rules can be found here. \nThe purpose of this workshop is to give existing competitors and those interested in competing more information regarding the Longitude Prize competition to help steer projects toward a winning configuration\, hear from experts on test needs in the United Kingdom (National Health Service) and lower and middle-income contexts (LMICs)\, and to provide a chance for test developers to engage with Longitude judges and the Nesta Team. \nThe Longitude Prize is hosted and managed by the Challenge Prize Centre at Nesta\, the Innovation Foundation based in London. \nPlease RSVP to Ruth Neale at ruth.neale@nesta.org.uk by Friday March 8\, 2019 if you plan to attend the workshop.
URL:https://carb-x.org/event/longitude-prize-boston-workshop/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190325
DTEND;VALUE=DATE:20190328
DTSTAMP:20260403T202653
CREATED:20190208T165741Z
LAST-MODIFIED:20190215T143737Z
UID:2384-1553472000-1553731199@carb-x.org
SUMMARY:Inaugural Bacteriophage Therapy Summit
DESCRIPTION:Speakers include Karen Gallant\, CARB-X Global Project Director. \nThe 1st Bacteriophage Therapy Summit is the only meeting uniting large pharma\, biotech companies\, research institutions and technology experts to harness bacteriophage science and accelerate the clinical development of effective phage therapy. Join the leaders in phage therapy product development as they discuss the latest data-driven case studies and forge collaborations you need to unlock the full potential of bacteriophage therapeutics. \nSee the full agenda and speaker list here. \nCARB-X subscribers qualify for an exclusive 10% discount with VIP Code 12259CARBX.
URL:https://carb-x.org/event/bacteriophage-therapy-summit/
LOCATION:Revere Boston Common\, 200 Stuart St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190327
DTSTAMP:20260403T202653
CREATED:20181129T151152Z
LAST-MODIFIED:20190214T181823Z
UID:2030-1553558400-1553644799@carb-x.org
SUMMARY:The Economist Antimicrobial Resistance Summit - Preventing an Antibiotic Apocalypse
DESCRIPTION:Speakers include Kevin Outterson\, CARB-X Executive Director. \nJoin 120+ health policy leaders\, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control\, before it is too late. A series of expert panel discussions will dig into the topics that matter the most\, using the convening power of The Economist brand to get the right people working together.
URL:https://carb-x.org/event/antimicrobial-resistance-preventing-an-antibiotic-apocalypse/
LOCATION:BMA House Conference and Events Venue\, Tavistock Square\, Bloomsbury\, London\, WC1H 9JP\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20190328T170000
DTEND;TZID=Europe/Paris:20190328T183000
DTSTAMP:20260403T202653
CREATED:20190206T171101Z
LAST-MODIFIED:20190327T134854Z
UID:2349-1553792400-1553797800@carb-x.org
SUMMARY:GARDP Webinar - Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar\, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. \nThe webinar will be held from 5:00 pm – 6:30 pm CET / 12:00 pm – 13:30 pm EDT. \nThe presentations will be followed by a Q&A session.
URL:https://carb-x.org/event/webinar-clinical-development-for-non-developers-part-3-antibacterial-drug-enhancer-combinations-and-non-traditional-products/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190401
DTEND;VALUE=DATE:20190402
DTSTAMP:20260403T202653
CREATED:20190418T170357Z
LAST-MODIFIED:20190418T170357Z
UID:2732-1554076800-1554163199@carb-x.org
SUMMARY:REPAIR Impact Fund is open for investment proposals...
DESCRIPTION:…from European life science companies until May 10. Information about how to apply can be found at here.\n\nThe REPAIR Impact Fund is now open for investment proposals from European life science companies targeting AMR. Companies are invited to submit a non-confidential proposal\, which will be evaluated during the spring. Successful projects will be invited to submit more extensive confidential proposals.\n\nThe window for submissions will be open until May 10th. Additional information and the proposal template can be found here.\n\nThis investment round is the second to European companies. Companies that took part in the first investment round without obtaining funding are very welcome to take part in this new round.
URL:https://carb-x.org/event/repair-impact-fund-is-open-for-investment-proposals/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190413
DTEND;VALUE=DATE:20190417
DTSTAMP:20260403T202653
CREATED:20190201T193554Z
LAST-MODIFIED:20190201T193554Z
UID:2263-1555113600-1555459199@carb-x.org
SUMMARY:Annual ECCMID Meeting
DESCRIPTION:ECCMID\, as the world’s premier Clinical Microbiology & Infectious Diseases event\, brings together experts from many fields to present their latest findings\, guidelines and experiences to an audience of over 12\,000 colleagues. This year\, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions\, as well as interactive workshops\, meet-the-expert sessions\, and a wide range of symposia.
URL:https://carb-x.org/event/annual-eccmid-meeting/
LOCATION:RAI Amsterdam\, Europaplein\, Amsterdam\, NL 1078 GZ\, Netherlands
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190415
DTEND;VALUE=DATE:20190416
DTSTAMP:20260403T202653
CREATED:20180627T152752Z
LAST-MODIFIED:20190214T185905Z
UID:1605-1555286400-1555372799@carb-x.org
SUMMARY:19th World Vaccine Congress
DESCRIPTION:Speakers include Dr. Barry Eisenstein\, Chair of the CARB-X Advisory Board. \nFor the past 18 years\, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally\, with:  300 speakers\, 1500 attendees and hundreds of networking opportunities.  This year’s congress will feature a variety of  pre-congress workshops and conferences in: \n\n\nCancer Immunotherapy\nImmune Profiling\nRespiratory Vaccines\nEmerging & Re-emerging Diseases\nClinical Trials\nVaccine Partnerships\nBioprocessing & Manufacturing\nVaccines Safety\nLogistics\nVeterinary Vaccines\n\n\n\nThroughout these sessions participants will learn how cutting-edge research efforts can be integrated with pharma\, biotech\, academia and government to produce more and better vaccines to the market.
URL:https://carb-x.org/event/19th-world-vaccine-congress-presentation-by-barry-eisenstein/
LOCATION:Renaissance Washington DC Downtown Hotel\, 999 9th St NW\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260403T202653
CREATED:20190201T193953Z
LAST-MODIFIED:20190214T190048Z
UID:2266-1555372800-1555631999@carb-x.org
SUMMARY:ICOHAR\, International Conference on One Health Antimicrobial Resistance
DESCRIPTION:It is generally recognized that control and prevention of antimicrobial resistance (AMR) requires a holistic One Health approach involving specialists from different sectors. In line with this concept\, the 2nd ICOHAR aims to bring together representatives from all relevant sectors (e.g. public health\, human and veterinary medicine\, livestock production\, food safety and environmental sciences) to share research and education strategies for understanding and reducing the risks of AMR at the interphase between humans\, animals and the environment. The programme does not only focus on zoonotic transfer of AMR but also on the numerous AMR-related challenges shared by clinicians\, clinical microbiologists\, infectious disease specialists and researchers working in these sectors. \nTo view the program\, please click here.
URL:https://carb-x.org/event/icohar-international-conference-on-one-health-antimicrobial-resistance/
LOCATION:Jaarbeusplein\, Ulrecht\, Netherlands
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190424
DTEND;VALUE=DATE:20190427
DTSTAMP:20260403T202653
CREATED:20190201T194317Z
LAST-MODIFIED:20190214T190219Z
UID:2269-1556064000-1556323199@carb-x.org
SUMMARY:Annual SHEA (Soc. for Hospital Epidemiology of America) Spring meeting
DESCRIPTION:This conference is designed for physicians\, infection preventionists\, healthcare epidemiologists\, infectious disease specialists\, microbiologists\, nurses\, pharmacists\, and other healthcare professionals interested in healthcare epidemiology\, infection prevention\, Antimicrobial Stewardship\, surveillance\, research methods\, patient safety\, environmental issues\, and quality improvement. \nThe SHEA 2019 Program Committee combines the expertise of SHEA members who have served on SHEA meeting planning committees for many years and active leaders from the SHEA Education Committee. It also includes broad subject matter expertise in healthcare epidemiology\, antibiotic stewardship\, long-term care\, research methods\, clinical microbiology\, patient safety and quality\, implementation science\, and a wide range of opportunities for networking and communication with peers and experts in the field. \nTo view the agenda\, please click here.
URL:https://carb-x.org/event/annual-shea-soc-for-hospital-epidemiology-of-america-spring-meeting/
LOCATION:Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190428
DTEND;VALUE=DATE:20190502
DTSTAMP:20260403T202653
CREATED:20190201T191908Z
LAST-MODIFIED:20190214T190616Z
UID:2250-1556409600-1556755199@carb-x.org
SUMMARY:National Academy of Sciences 155th Annual Meeting
DESCRIPTION:Advising the Nation. Advancing the Discussion. Connecting New Frontiers. \nSociety is facing an array of complex policy questions. The National Academies of Sciences\, Engineering\, and Medicine provides nonpartisan\, objective guidance for decision makers on pressing issues. and marshals the energy and intellect of the nation’s critical thinkers to respond to policy challenges with science\, engineering\, and medicine at their core. \nThrough a meticulous process of information collection\, evidence analysis\, and deliberation\, NAS studies provide blueprints for progress. By shining a spotlight on subjects and facilitating dialogue across disciplines\, their work advances understanding of critical issues. \nFor information on live webcasts\, click here.  \nFor information on the agenda click here. \nVisit the NAS website here.
URL:https://carb-x.org/event/national-academy-of-sciences-155th-annual-meeting/
LOCATION:National Academy of Sciences\, 2101 Constitution Ave.\, N.W.\, Washington\, DC\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190512
DTSTAMP:20260403T202653
CREATED:20190201T195029Z
LAST-MODIFIED:20190214T191346Z
UID:2272-1557100800-1557619199@carb-x.org
SUMMARY:37th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)
DESCRIPTION:The 37​th Annual Meeting of the European Society for Paediatric Infectious Diseases will feature a wide range of sessions and learning opportunities showcasing the latest research and developments in the field hosted by leading international experts.  The meeting aims to bring together the most prominent researchers in the field of paediatric infectious diseases\, immunology and epidemiology and to fill in the gaps between these disciplines in a relaxed\, smart albeit casual atmosphere.
URL:https://carb-x.org/event/37th-annual-meeting-of-the-european-society-for-paediatric-infectious-diseases-espid/
LOCATION:Ljubljana\, Slovenia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190516T090000
DTEND;TZID=America/New_York:20190516T100000
DTSTAMP:20260403T202653
CREATED:20190509T203055Z
LAST-MODIFIED:20190528T161825Z
UID:2992-1557997200-1558000800@carb-x.org
SUMMARY:Live Webinar: CARB-X 2019 Funding Rounds
DESCRIPTION:Kevin Outterson\, CARB-X Executive Director\, and Karen Gallant\, CARB-X Global R&D Project Director\, present details of CARB-X’s four new funding rounds announced April 30\, 2019\, and answer questions during this webinar. To attend the live webinar\, please register by clicking the link below. A recording of the webinar will be available for viewing shortly after the event. The recording will be available on the CARB-X website in the Apply > What CARB-X funds section. \nPlease click here to register.
URL:https://carb-x.org/event/carb-x-2019-funding-rounds-webinar/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
ORGANIZER;CN="CARB-X":MAILTO:carbx@bu.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190521T170000
DTEND;TZID=Europe/Helsinki:20190521T183000
DTSTAMP:20260403T202653
CREATED:20190314T170711Z
LAST-MODIFIED:20190404T155846Z
UID:2558-1558458000-1558463400@carb-x.org
SUMMARY:GARDP Mining Chemical Libraries for New Antibacterials
DESCRIPTION:Despite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nThe overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar\, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. \nPlease note\, this webinar has been rescheduled from April 4th to May 21st\, 2019. \nThe webinar will be held from 5:00 pm – 6:30 pm CEST / 11:00 pm – 12:30 pm EDT. \nThe presentation will be followed by a Q&A session. \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190528
DTEND;VALUE=DATE:20190529
DTSTAMP:20260403T202653
CREATED:20190305T210241Z
LAST-MODIFIED:20190501T141348Z
UID:2489-1559001600-1559087999@carb-x.org
SUMMARY:Global AMR R&D Hub “Increasing Investments for AMR R&D” Workshop
DESCRIPTION:Participants include Kevin Outterson\, Executive Director of CARB-X. \nThe Global AMR R&D Hub is pleased to announce a one-day workshop on “Increasing Investments\nfor AMR R&D”\, which will take place on Tuesday May 28 2019 in Geneva\, Switzerland. The event\nwill gather representatives from governments\, funders\, industry\, investors and other stakeholders\ninterested in the field of antimicrobial resistance. \nAntimicrobial resistance (AMR) represents an urgent major global health threat. Currently\, there is\nan insufficient number of treatments and tools in the AMR research and development (R&D)\npipeline to tackle this issue. Building on ongoing initiatives\, increasing investments across the One\nHealth spectrum is required. In particular\, more effort is needed in the animal and plant fields as\nwell as applicability in low- and middle-income countries (LMIC). \nThis workshop aims to discuss investments and financing mechanisms for AMR R&D and provide\nrecommendations for funders and investors on how to address the vital issue of increasing\ninvestments in AMR R&D in a One Health context that also considers applicability in LMIC. \nPlease click here to learn more. \n 
URL:https://carb-x.org/event/global-amr-rd-hub-increasing-investments-for-amr-rd-workshop/
LOCATION:Domaine de Penthes\, Chemin de l'Impératrice 18\, Pregny-Chambésy\, 1292\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190531T100000
DTEND;TZID=America/New_York:20190531T114500
DTSTAMP:20260403T202653
CREATED:20190529T132958Z
LAST-MODIFIED:20190529T132958Z
UID:3069-1559296800-1559303100@carb-x.org
SUMMARY:CARB-X Presentation: 2019 Funding Rounds
DESCRIPTION:Presentation by Karen Gallant\, CARB-X Acting R&D Chief/Deputy Director.  Attendees include Richard Alm\, CARB-X Alliance Director. \nPlease join NCBiotech and RTI International as we host CARB-X Global R&D Project Director Karen Gallant for an informational session about CARB-X and the upcoming funding rounds. Karen will provide an overview of the CARB-X initiative and leave plenty of time to get all questions answered. This event is FREE to attend. \nFor further information\, please refer to the CARB-X press release and website. \n\nAgenda\n10:00 a.m. – Presentation by Karen Gallant\, Global R&D Project Director\, CARB-X\n10:30 a.m. – Presentation: RTI International as a CARB-X Accelerator\n10:45 a.m. – Q&A Session\n11:15 a.m. – Networking\n11:45 a.m. – Adjourn \n\n\nRegistration\nThere is some availability for a few companies to have one-on-one meetings with CARB-X. If you are interested\, please select that option on the registration page.
URL:https://carb-x.org/event/carb-x-presentation-2019-funding-rounds/
LOCATION:North Carolina Biotechnology Center\, 15 T.W. Alexander Drive\, Research Triangle Park\, NC\, 27709-3547\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190607
DTSTAMP:20260403T202653
CREATED:20190201T195534Z
LAST-MODIFIED:20190214T191645Z
UID:2275-1559520000-1559865599@carb-x.org
SUMMARY:2019 BIO International Convention
DESCRIPTION:The BIO International Convention (BIO) attracts 16\,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery\, biomanufacturing\, genomics\, biofuels\, nanotechnology and cell therapy. \nThe key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering\, exposure to industry thought-leaders with over 500 education sessions at your fingertips\, and unparalleled networking opportunities with 16\,000+ attendees from 67 countries. \nSee the schedule here.
URL:https://carb-x.org/event/2019-bio-international-convention/
LOCATION:Philadelphia Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190604T133000
DTEND;TZID=Europe/Berlin:20190604T150000
DTSTAMP:20260403T202653
CREATED:20190528T155449Z
LAST-MODIFIED:20190528T160555Z
UID:3052-1559655000-1559660400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl. \nDespite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nSpeakers:\nCarl Balibar\, Principal Scientist\, Merck Research Laboratories \nModerator:\nBenjamin Blasco\, Discovery Senior Project Manager\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials-session-2/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260403T202653
CREATED:20190226T195721Z
LAST-MODIFIED:20190305T211145Z
UID:2461-1559692800-1559865599@carb-x.org
SUMMARY:Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium
DESCRIPTION:Panelists members include Kevin Outterson\, Executive Director of CARB-X\, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel. \n\n\n\nThis panel will discuss the use of public-private partnerships as models for stimulating innovation through sponsored research and development. The panelists will provide overviews of several partnership-enabled consortia and accelerators\, including BARDA’s new Division of Research\, Innovation\, and Ventures and their participation in the partnership\, Combating Antibiotic Resistant Bacteria\, and\, as well as DoD’s Medical CBRN Defense Consortium and Medical Technology Enterprise Consortium. Presenters will discuss their organization’s background and structure\, as well as their unique mechanisms for engaging the research community to solve significant public health and biomedical challenges. \n\n\n\nThe Symposium will focus on two separate tracts. The first\, “Medical Support to the Warfighter\,” will connect businesses and university researchers with military and other federal agencies that require or purchase medical supplies\, equipment\, devices\, pharmaceuticals\, information technology and services\, or fund medical-related research and development. \nThe second tract\, “Biomedical and Biodefense Support to the Warfighter\,” will focus on establishing dialogue between industry and academia-based technology innovators and military and government officials to address the future biomedical and biodefense needs of the military and our nation. \n\nTo learn more\, please click here.
URL:https://carb-x.org/event/medical-biomedical-biodefense-support-to-the-warfighter-symposium/
LOCATION:The Friday Conference Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190611T100000
DTEND;TZID=America/New_York:20190611T110000
DTSTAMP:20260403T202653
CREATED:20190517T135538Z
LAST-MODIFIED:20190528T155538Z
UID:3015-1560247200-1560250800@carb-x.org
SUMMARY:Live Webinar: Funding Opportunities for Antimicrobial Drug Development from the Cystic Fibrosis Foundation
DESCRIPTION:Interested in new funding opportunities for infection drug development?\nThe Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11\, from 10:00am – 11:00am ET\, to introduce their new Infection Research Initiative. \nDuring the webinar\, Dr. Ann Field\, Senior Director of Drug Discovery and Development at the Cystic Fibrosis Foundation\, will discuss potential funding opportunities for therapeutic development of anti-infectives in key organisms of interest for CF infections.  The presentation will be followed by an interactive Q&A session. \nWebinar Summary\nLearn about funding opportunities for infection drug development through the Cystic Fibrosis Foundation. This webinar will include: \n\nOverview of the CF Foundation and the recently announced Infection Research Initiative\nCF Foundation interest in supporting therapeutic development for anti-infectives in key organisms of interest for CF infections\nTherapeutic Development Award Process and collaboration opportunities\n\nTo join this webinar\, please register here. \nIf you have questions or comments\, please let us know. Feel free to email your questions or comments to Raj Shetty at dshetty@carbx.org before the webinar\, or save them for the live Q&A session following the presentation.  We look forward to hearing from you!
URL:https://carb-x.org/event/webinar-funding-opportunities-for-antimicrobial-drug-development-from-the-cystic-fibrosis-foundation/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190611T170000
DTEND;TZID=Europe/Berlin:20190611T183000
DTSTAMP:20260403T202653
CREATED:20190528T160224Z
LAST-MODIFIED:20190528T160702Z
UID:3058-1560272400-1560277800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, William J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy\, will introduce experimental design of animal models for antimicrobial research. He will discuss questions such as 1) Where to start and what model to use? 2) Are animal models of bacterial infection reflective of the clinical condition? 3) Are in vivo animal model results predictive of clinical efficacy? The presentation will be followed by a Q&A session moderated by Peter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec. \nSpeakers:\nWilliam J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy \nModerator:\nPeter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-development-and-use-of-in-vivo-models-for-infectious-disease-research/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190625
DTSTAMP:20260403T202653
CREATED:20190201T200421Z
LAST-MODIFIED:20190214T191858Z
UID:2280-1560988800-1561420799@carb-x.org
SUMMARY:ASM Microbe 2019
DESCRIPTION:Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties\, discover cutting-edge research in the poster and oral presentations\, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.
URL:https://carb-x.org/event/asm-microbe-2019/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190624T071500
DTEND;TZID=America/Los_Angeles:20190624T081500
DTSTAMP:20260403T202653
CREATED:20190207T143629Z
LAST-MODIFIED:20190214T192046Z
UID:2360-1561360500-1561364100@carb-x.org
SUMMARY:ASM Microbe Breakout Session - Enabling Academia to Fill the Discovery Gap
DESCRIPTION:Presentations developed in cooperation with GARDP\, CARB-X\, and REPAIR Impact Fund. \nAntimicrobial resistance (AMR) continues to be a major problem that is not being addressed adequately by the pharmaceutical industry. Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session\, drug discovery efforts originating from academic laboratories will be discussed. The importance of collaborative efforts will be emphasized.
URL:https://carb-x.org/event/enabling-academia-to-fill-the-discovery-gap-developed-in-cooperation-with-gardp-carb-x-and-repair-impact-fund/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190629
DTSTAMP:20260403T202653
CREATED:20190206T170153Z
LAST-MODIFIED:20190227T152450Z
UID:2342-1561420800-1561766399@carb-x.org
SUMMARY:International Council of Academies of Engineering and Technological Sciences (CAETS) Conference
DESCRIPTION:Speakers include Kevin Outterson\, Executive Director of CARB-X. \nThe Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and Technological Sciences (CAETS) in 2019. CAETS in a independent non-political\, non-governmental international organization of engineering and technological science academies worldwide. The conference will focus on what engineering and technological science has accomplished in the last 100 years as well as future challenges\, focusing on the topics of Health\, Energy\, Affordable Living\, Superintelligens and Distrubution of Resources. The conference will focus on how engineering and technological science can morph into the future and contribute to solutions. \n 
URL:https://carb-x.org/event/international-council-of-academies-of-engineering-and-technological-sciences-caets-conference/
LOCATION:Stockholm\, Stockholm\, Sweden
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190626T103000
DTEND;TZID=America/New_York:20190626T113000
DTSTAMP:20260403T202653
CREATED:20190620T134850Z
LAST-MODIFIED:20190620T134850Z
UID:3143-1561545000-1561548600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
DESCRIPTION:In this webinar\, Dr Manica Balasegaram\, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan\, and share GARDP’s updated strategy. Following his presentation\, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz\, GARDP’s Director of External Affairs. \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-find-out-how-gardp-is-redoubling-its-efforts-to-accelerate-the-development-and-delivery-of-new-and-improved-antibiotics/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190705
DTEND;VALUE=DATE:20190706
DTSTAMP:20260403T202653
CREATED:20190201T204108Z
LAST-MODIFIED:20190201T204108Z
UID:2295-1562284800-1562371199@carb-x.org
SUMMARY:Institut Pasteur Financing Start-Ups in Life Sciences Workshop
DESCRIPTION:Additional Details Forthcoming.
URL:https://carb-x.org/event/institut-pasteur-financing-start-ups-in-life-sciences-workshop/
END:VEVENT
END:VCALENDAR